PLSE FY 2024 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

PLSEPulse Biosciences, Inc.

$1B

FY 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$56M

Net Income

-$54M

EPS (Diluted)

$-0.92

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$36M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$132M

Total Liabilities

$18M

Stockholders' Equity

$115M

Cash & Equivalents

$118M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$1M	+100.0%
Operating Income	-$56M	-$44M	-29.1%
Net Income	-$54M	-$42M	-26.9%